Antibiotic producing potentials of three freshwater actinomycetes isolated from the Eastern Cape Province of South Africa

International Journal of Molecular Sciences

Volumn 11, Issue 7, 2010, Pages 2612-2623

  Sibanda, Timothy ^a   Mabinya, Leonard V ^a   Mazomba, Ntsikelelo ^a   Akinpelu, David A ^b   Bernard, Kim ^c   Olaniran, Ademola O ^d   Okoh, Anthony I ^a  

^a UNIVERSITY OF FORT HARE   (South Africa)

^b OBAFEMI AWOLOWO UNIVERSITY   (Nigeria)

^c SOUTH AFRICAN ENVIRONMENTAL OBSERVATION NETWORK   (South Africa)

^d UNIVERSITY OF KWAZULU NATAL   (South Africa)

Author keywords

Actinomycetes; Antibacterial activity; Crude extract; Time kill

Indexed keywords

ANTIBIOTIC AGENT;

ACTINOBACTERIA; ACTINOSYNNEMA; ANTIBACTERIAL ACTIVITY; ANTIBIOTIC SENSITIVITY; ARTICLE; BACILLUS PUMILUS; BACTERIAL STRAIN; BACTERIOSTASIS; BACTERIUM ISOLATION; COLONY FORMING UNIT; FERMENTATION; FRESHWATER SPECIES; GRAM NEGATIVE BACTERIUM; GRAM POSITIVE BACTERIUM; KLEBSIELLA PNEUMONIAE; MINIMUM INHIBITORY CONCENTRATION; NONHUMAN; PROTEUS VULGARIS; PSEUDOMONAS AERUGINOSA; SACCHAROPOLYSPORA; SOUTH AFRICA; STAPHYLOCOCCUS EPIDERMIDIS;

ACTINOMYCETES; ANTIBACTERIAL ACTIVITY; CRUDE EXTRACT; TIME-KILL;

ACTINOBACTERIA; ANTI-BACTERIAL AGENTS; FRESH WATER; MICROBIAL SENSITIVITY TESTS; SOUTH AFRICA; WATER MICROBIOLOGY;

ACTINOBACTERIA (CLASS); ACTINOSYNNEMA; BACILLUS PUMILUS; BACTERIA (MICROORGANISMS); KLEBSIELLA PNEUMONIAE; NEGIBACTERIA; POSIBACTERIA; PROTEUS VULGARIS; PSEUDOMONAS AERUGINOSA; SACCHAROPOLYSPORA; STAPHYLOCOCCUS EPIDERMIDIS;

EID: 77955085503     PISSN: None     EISSN: 14220067     Source Type: Journal    
DOI: 10.3390/ijms11072612     Document Type: Article

References (33)

1. Sathi, Z.S.; Rahman M.A.A.; Gafur, M.A. Identification and in vitro anti microbial activity of a compound isolated from Streptomyces species. Pak. J. Biol. Sci. 2001, 4, 1523-1525.
2. Hongjuan, Z.; Rachel, L.P.; David, I.E.; Gareth, W.G; Royston, G. The rapid differentiations of Streptomyces using fourier transform infrared spectroscopy. Vibrat. Spectr. 2006, 40, 213-218.
3. Miyado, S. Research on antibiotic screening in Japan over the last decade: A producing microorganism approach. Actinomycelogica 1993, 7, 100-106.
4. Williams, P.G.; Buchanan, G.O.; Feling, R.H.; Kauffman, C.A.; Jensen, P.R.; Fenical, W. New cytotoxic salinosporamides from marine actinomycete Salinispora tropica. J. Org. Chem. 2005, 70, 6196-6203.
5. Glen, P.; Eccleston, P.R.; Brooks, D. The occurrence of bioactive Micromonosporae in aquatic habitats of the sunshine coast in Australia. Mar. Drugs 2008, 6, 243-261.
6. Beaman, B.L. Mechanisms of pathogenesis and host resistance to the actinomycetes. Zbl. Bakt. Suppl. 1981, 11, 209-220.
7. Berkow, R.; Fletcher, A.J. The Merck Manual of Diagnosis and Therapy; Merck & Company Inc.: Rahway, NJ, USA, 1992.
8. Goodfellow, M.; O'Donnell, A.G. Search and discovery of industrially-significant actinomycetes. Soc. Gen. Microbio. Symp. 1989, 44, 343-383.
9. Mustafa, S.A.; Tamer, U.A.; Azer, C. Antibacterial activity of some actinomycetes isolated from farming soils of Turkey. Afr. J. Biotech. 2004, 3, 441-446.
10. Abbanat, D.; Macielag, M.; Bush, K. Novel antibacterial agents for the treatment of serious Gram- positive infections. Expert Opin. Investig. Drugs 2003, 12, 379-399.
11. Koehn, F.E; Carter, G.T. The evolving role of natural products in drug discovery. Nat. Rev. Drug Disc. 2005, 4, 206-20.
12. Ogunmwonyi, I.N.H. Actinomycetes diversity of Tyume River and Nahoon beach. Honors dissertation submitted to Department of Biochemistry and Microbiology, University of Fort Hare: Alice, South Africa, 2008.
13. Hasegawa, T.; Tanida, S.; Hatano, K.; Higashide, E.; Yoneda, M. Motile Actinomycetes: Actinosynnema pretiosum sp. nov., subsp. nov., and pretiosum subsp Actinosynnema pretiosum subsp. auranticum subsp. nov. Intern. J. Syst. Bact. 1983, 4, 314-320.
14. Lacey, J.; Goodfellow, M. A novel actinomycete from sugar-cane bagasse: Saccharopolyspora hirsuta gen. et sp. nov. J. Gen. Microbiol. 1975, 88, 75-85.
15. Rifaat, H.M. The biodiversity of actinomycetes in the River Nile exhibiting antifungal activity. J. Mediter. Ecol. 2003, 4, 5-7.
16. Zhang, L.; An, R.; Wang, J.; Sun, N.; Zhung, S.; Hu, J. Exploring novel bioactive compounds from marine microbes. Curr. Opin. Microbio. 2005, 8, 276-281.
17. Nolan, R.D.; Cross, T. Isolation and screening of actinomycetes. In Actinomycetes in Biotechnology; Goodfellow, M., Williams, S.T., Mordarski, M., Eds. Academic Press, Inc.: San Diego, CA, USA, 1988; pp. 1-32.
18. Bhattacharyya, B.K.; Pal, S.C.; Sen, S.K. Antibiotic production by Streptomyces hydroscopicus. Cult. Effect 1998, 21, 17-23.
19. Parungawo, M.M.; Maceda, E.B.G.; Villano, M.A.F. Screening of antibiotic producing actinomycetes from marine, brackish and terrestrial sediments of Samal Islands, Philippines. J. Res. Sci. 2007, 4, 29-38.
20. Hiramatsu, K.; Hanaki, H.; Ino, T.; Yabuta, K.; Oguri, T.; Tenover, F.C. Methicillin resistant Staphylococcus aureus clinical strain with reduced vancomycin susceptibility. J. Antimicrob. Chem. 1997, 42, 315-320.
21. Todar K., Pathogenic E. Coli: Todar's online textbook of bacteriology. 2002. Available at: http://textbookofbacteriology.net/e.coli.html (accessed on 17 November 2009).
22. Pupo, G.M.; Karaolis, D.K.; Lan, R.; Reeves, P.R. Evolutionary relationships among pathogenic and non-pathogenic Escherichia coli strains inferred from multilocus enzyme electrophoresis and mdh sequence studies. Infect. Immun. 1997, 65, 2685-2692.
23. Zgurskaya, H.I.; Nikaido, H. Multidrug resistance mechanisms: Drug efflux across two membranes. Mol. Microbiol. 2000, 37, 219-225.
24. Pankey, G.A.; Sabath, L.D. Clinical relevance of bacteriostatic versus bactericidal mechanisms of action in the treatment of gram positive bacterial infections. Clin. Inf. Dis. 2004, 38, 864-870.
25. Muiru, W.M.; Mutitu, E.W.; Mukunya, D.M. Identification of selected actinomycetes isolates and characterisation of their antibiotic metabolites. J. Biol. Sci. 2008, 8, 1021-1026.
26. Liu, C.; Tadayoni, B.M.; Bourret, L.A.; Mattocks, K.M.; Derr, S.M.; Widdison, W.C.; Kedersha, N.L.; Ariniello, P.D.; Goldmacher, V.S.; Lambert, J.M.; Blattler, W.A.; Chari, R.V. Eradication of large colon tumor xenografts by targeted delivery of maytansinoids. Proc. Natl. Acad. Sci. 1996, 93, 8618-8623.
27. Pandey, B.; Ghimire, P.; Agrawal, V.P. Studies on the antibacterial activity of the actinomycetes isolated from the Khumbu region of Nepal. Appl. Microbiol. 2008, 5, 235-261.
28. EUCAST. Terminology relating to methods for the determination of susceptibility of bacteria to antimicrobial agents. Clin. Microbiol. Infect. 2000, 6, 503-508.
29. EUCAST (European Committee for Antimicrobial Susceptibility Testing). Determination of Minimum lnhibitory Concentration (MICs) of antimicrobial agents by broth dilution. Clin. Microbial. Infect. 2003, 9, 1-7.
30. Tenover, F.C. Implementation of NCCLS antimicrobial susceptibility testing standards. 2002. Available at: http://wwwn.cdc.gov/cliac/pdf/addenda/cliac0904/Addendum_W.pdf (accessed on 30 June 2010).
31. Okoli, S.; Iroegbu, C.U. In vitro antibacterial activity of Synclisa scabrida whole root extract. Afr. J. Biotech. 2005, 4, 946-952.
32. Aiyegoro, O.A.; Afolayan, A.J.; Okoh A.I. In vitro time kill assessment of crude methanol extract of Helichrysum pedunculatum leaves. Afr. J. Biotech. 2008, 7, 1684-1688.
33. Sibanda, T.; Okoh, A.I. In vitro antibacterial regimes of crude aqueous and acetone extracts of Garcinia kola seeds. J. Biol. Sci. 2008, 8, 149-154.